BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29637577)

  • 1. Are age and gender suitable matching criteria in organ dose reconstruction using surrogate childhood cancer patients' CT scans?
    Wang Z; van Dijk IWEM; Wiersma J; Ronckers CM; Oldenburger F; Balgobind BV; Bosman PAN; Bel A; Alderliesten T
    Med Phys; 2018 Jun; 45(6):2628-2638. PubMed ID: 29637577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do patient characteristics and anatomical features correlate to accuracy of organ dose reconstruction for Wilms' tumor radiation treatment plans when using a surrogate patient's CT scan?
    Wang Z; Balgobind BV; Virgolin M; van Dijk IWEM; Wiersma J; Ronckers CM; Bosman PAN; Bel A; Alderliesten T
    J Radiol Prot; 2019 Jun; 39(2):598-619. PubMed ID: 30965301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic multiorgan segmentation in thorax CT images using U-net-GAN.
    Dong X; Lei Y; Wang T; Thomas M; Tang L; Curran WJ; Liu T; Yang X
    Med Phys; 2019 May; 46(5):2157-2168. PubMed ID: 30810231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogate-free machine learning-based organ dose reconstruction for pediatric abdominal radiotherapy.
    Virgolin M; Wang Z; Balgobind BV; van Dijk IWEM; Wiersma J; Kroon PS; Janssens GO; van Herk M; Hodgson DC; Zadravec Zaletel L; Rasch CRN; Bel A; Bosman PAN; Alderliesten T
    Phys Med Biol; 2020 Dec; 65(24):245021. PubMed ID: 32580177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study evaluating the use of IV contrast on IMRT treatment planning for lung cancer.
    Li H; Bottani B; DeWees T; Low DA; Michalski JM; Mutic S; Bradley JD; Robinson CG
    Med Phys; 2014 Mar; 41(3):031708. PubMed ID: 24593712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the feasibility of automatically selecting similar patients in highly individualized radiotherapy dose reconstruction for historic data of pediatric cancer survivors.
    Virgolin M; van Dijk IWEM; Wiersma J; Ronckers CM; Witteveen C; Bel A; Alderliesten T; Bosman PAN
    Med Phys; 2018 Apr; 45(4):1504-1517. PubMed ID: 29430662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric evaluation of synthetic CT for magnetic resonance-only based radiotherapy planning of lung cancer.
    Wang H; Chandarana H; Block KT; Vahle T; Fenchel M; Das IJ
    Radiat Oncol; 2017 Jun; 12(1):108. PubMed ID: 28651599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body region-specific 3D age-scaling functions for scaling whole-body computed tomography anatomy for pediatric late effects studies.
    Gupta AC; Owens CA; Shrestha S; Lee C; Smith SA; Weathers RE; Netherton T; Balter PA; Kry SF; Followill DS; Griffin KT; Long JP; Armstrong GT; Howell RM
    Biomed Phys Eng Express; 2022 Feb; 8(2):. PubMed ID: 34874300
    [No Abstract]   [Full Text] [Related]  

  • 11. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy.
    Nakamura A; Shibuya K; Nakamura M; Matsuo Y; Shiinoki T; Nakata M; Mizowaki T; Hiraoka M
    Med Phys; 2013 Feb; 40(2):021701. PubMed ID: 23387724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison of intensity-modulated radiotherapy plans, with or without anterior myocardial territory and left ventricle as organs at risk, in early-stage left-sided breast cancer patients.
    Tan W; Wang X; Qiu D; Liu D; Jia S; Zeng F; Chen Z; Li B; Xu J; Wei L; Hu D
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1544-51. PubMed ID: 21470785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized 3D reconstruction of normal tissue dose for patients with long-term follow-up: a step toward understanding dose risk for late toxicity.
    Ng A; Brock KK; Sharpe MB; Moseley JL; Craig T; Hodgson DC
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e557-63. PubMed ID: 22929861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive stereotactic body radiation therapy planning for lung cancer.
    Qin Y; Zhang F; Yoo DS; Kelsey CR; Yin FF; Cai J
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):209-15. PubMed ID: 23790773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CT images with average intensity projection, free breathing, and mid-ventilation for dose calculation in lung cancer.
    Khamfongkhruea C; Thongsawad S; Tannanonta C; Chamchod S
    J Appl Clin Med Phys; 2017 Mar; 18(2):26-36. PubMed ID: 28300381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.
    Oechsner M; Odersky L; Berndt J; Combs SE; Wilkens JJ; Duma MN
    Radiat Oncol; 2015 Dec; 10():249. PubMed ID: 26626865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of deformable registration on the dose calculated in radiation therapy planning CT scans of lung cancer patients.
    Cunliffe AR; Contee C; Armato SG; White B; Justusson J; Malik R; Al-Hallaq HA
    Med Phys; 2015 Jan; 42(1):391-9. PubMed ID: 25563279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
    Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.